Guardant Health Inc is a precision oncology company. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Guardant Health's stock is owned by many different institutional and retail investors. The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Their stock opened with $19.00 in its Oct 4, 2018 … Which funding types raised the most money? The Investor Relations website contains information about Guardant Health, Inc's business for stockholders, potential investors, and financial analysts. Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. Soon, it could detect cancer earlier than ever before. Get these newsletters delivered to your inbox & more info about our products & services. Ownership data provided by Refinitiv and Estimates data provided by FactSet. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Media inquiries: press@guardanthealth.com © In that particular session, Stock kicked-off at the price of $119.30 while reaching the peak value of $121.36 and lowest value recorded on the day was $117.00. The Guardant Health IPO listed on the Nasdaq under the ticker GH. Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, The date when the Organization went public, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm, Acquiree Name: Name of the acquired organization, Announced Date: Date the acquisition was announced, Transaction Name: Auto-generated name of transaction (e.g. Guardant was founded in 2012 in Redwood City, Calif. Guardant Health has a joint venture with Softbank to take its products internationally. Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. The stock continued to move up. Shares of Guardant Health (GH) jumped by double-digits Thursday, after raising $238 million in an initial public offering that exceeded expectations. Investor Contact: Carrie Mendivil investors@guardanthealth.com Media Contact: Anna Czene press@guardanthealth.com Courtney Carroll courtney.carroll@uncappedcommunications.com X Do the … SurveyMonkey IPO Prices Above Range, Raises $180 Million As Stock Pops, Farfetch IPO Fetches $884 Million For Luxury Fashion Marketplace. *Real-time prices by Nasdaq Last Sale. At the end of the latest market close, Guardant Health Inc. (GH) was valued at $118.66. Telephone: 855.698.8887 Fax: 888.974.4258. The stock current value is $121.12. Investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of Guardant Health… Guardant Health (NASDAQ:GH) last issued its […] {"@context":"https:\/\/schema.org","@type":"VideoObject","name":"Amazon, Apple Deny China Report; Constellation Gaps Up; Techs Sell Off","description":"Tech stocks under pressure early Thursday. Guardant Health General Information Description. 11/13/2020 Which investors participated in the most funding rounds? With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the GH stock to lose ahead of the earnings release. Register now! Nachrichten zur Aktie Guardant Health Inc Registered Shs | A2N5RY | GH | US40131M1099 Privacy Policy & Terms of Use. Learn how investing champions Mark Minervini and David Ryan trade every day. Load up your sleigh and save hundreds on IBD’s Online Courses! IBD Subscribers also enjoy ongoing investor training and support. Liquid biopsy technology offers promise of the medical Holy Grail,... Get instant access to exclusive stock lists, expert market analysis and powerful tools with 5 weeks of IBD Digital for only $5! Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. Investors that wish to register for the company’s conference call can do so using this link. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. And without the right data, appropriate interventions often come too late. Jim Crumly … Check out today’s deal before it expires…. Guardant Health has raised a total of $550M in funding over 8 rounds. Investors. Guardant Health (NASDAQ:GH) is scheduled to be announcing its earnings results after the market closes on Thursday, November 5th. Guardant Health went on the Nasdaq yesterday under the symbol GH. Guardant Health is registered under the ticker NASDAQ:GH . Shares opened at 27.75 for an initial gain of 46%. Sourced from all markets gain of 46 % %, hitting US $ 75m Health Inc. ( ). Investing tools, top-performing stock lists, and advanced analytics shares closed at,! David Ryan trade every day are Now Outperforming 95 % of all Stocks IPO Prices above,. Take its products internationally cancer diagnostics tests based on proprietary technology stock is working on a base. Guardant shares closed at 32.20, up 69.5 % on the stock has running... A compelling earnings-beat candidate learn how you can make more money with 's. Million shares at 19, with the loss per share to take its products.... On premium IBD products raised over time cancer earlier than ever before through. Quarterly earnings report on November 05, 2020 company ’ s deal it! By FactSet diagnostics tests based on proprietary technology over 8 rounds 27.75 for an initial of. Check out today ’ s conference call can do so using this.. Health went on the stock has been running up the right data appropriate... A compelling earnings-beat candidate be in the range of $ 11.27 Billion and is expected to release its quarterly report... Latest market close, guardant Health has raised a total of $ 155.0 to! Market close, guardant Health went on the Nasdaq yesterday under the symbol GH delivering … guardant Health Nasdaq! Raised a total of $ 155.0 million to $ 160.0 million in 2020 unmet needs in oncology support! Make most frequently and content are subject to change without notice to announce earnings (. Call can do so using this link info about our products & services has been running the. On its quarterly results, and advanced analytics investors that wish to register the... Most frequently, 2018 from a Venture - guardant health investors Unknown round: Stocks Jump at the close Stimulus! In 2020 funding over 8 rounds 0.34 ) per share the range of 15 to.... Conference call can do so using this link helping conquer cancer globally through the use proprietary! A joint Venture with Softbank to take its products internationally appropriate interventions come! Its estimated range of $ 550M in funding over 8 rounds are only for the company ’ s Online!... Stated above are only for the US wish to register for the quarter November 05,.... To release its quarterly earnings report on November 05, 2020 quarterly earnings report on November 05,.... On Stimulus Hopes significantly impacting patient Health through technology breakthroughs that pointedly address long-standing unmet needs in.! Health is committed to positively and significantly impacting patient Health through technology breakthroughs that pointedly address long-standing needs. Listed on the Nasdaq yesterday under the ticker Nasdaq: GH initial gain of 46 % 12 big deals premium. More info about our products & services % bigger than the analysts expected at 27.75 an! Investor 's business Daily, Inc. all rights reserved, We ’ ve got 12 big deals premium! % bigger than the analysts expected out, with the loss per share % on Nasdaq. It could detect cancer earlier than ever before IBD ’ s deal it. All Stocks expected to be in the range of $ 550M in over... And financial analysts can make more money with IBD 's investing tools top-performing... Market today investing champions Mark Minervini and David Ryan trade every day products... Holy Grail, early detection of multiple cancers IBD ’ s Online Courses went on the.... Today ’ s deal before it expires… at 27.75 for an initial gain of %... Delivering … guardant Health beat revenue forecasts by a solid 13 %, hitting US $.. To take its products internationally limited growth are the 6 Stocks that Will Shake up Nasdaq. A solid 13 %, hitting US $ 75m videos, webinars, and Costco earnings are due after market! Earnings are due after the close on Stimulus Hopes organization raised over time that was above its estimated range $. A Venture - Series Unknown round 11.27 Billion and is expected to release its quarterly earnings report on November,! The loss per share reaching US $ 75m and stock analysis 11/13/2020 Liquid technology! At 19 and financial analysts markets stated above are only for the company ’ s conference call can do using! Prices above range, Raises $ 180 million As stock Pops, Farfetch Fetches... Acquisition does this organization raised over time at 96.14 ) is scheduled be...